SpainSpain

Swine flu has reached Europe

29.04.2009

Spain's Health Ministry confirmed Europe's first case of swine flu on Monday. In the next 24 hours dozens of suspected cases cropped up all over Europe. On Tuesday, suspected cases were reported in Germany, the Czech Republic, Italy, Greece, Ireland, Denmark and Sweden.
The EU has called for an extraordinary meeting of health ministers and issued a travel advisory against non-essential trips to areas where the virus has surfaced. There's no European action plan against a pandemic. Each is taking measures on a national level, which are overseen by ECDC.
The virus is a novel human H1N1 influenza variant with genomic elements of human, avian and porcine flu viruses, which apparently is able to be transmitted from human to human but up to now has not been identified in pigs, acording to the Centers for Disease Control (CDC) in Atlanta.
So far the only "swine flu" deaths recorded have been in Mexico, where 7 people were confirmed to have died from the disease. The United States has recorded the second highest rate of infection, but no deaths.
Acting CDC director Richard Besser rejected a warning from EU Health Commissioner Androulla Vassiliou that appeared to call on Europeans to avoid travel to the United States and Mexico, calling it "quite premature." US virologists recommended not to panic but to analyse the virus’ target group and the number of confirmed cases.
Reports from the CDC indicate that the virus is susceptible to the usual neuraminidase blockers Oseltamivir (Tamiflu, Roche) and Zanamivir (Relenza, GlaxoSmithKline).
On Wednesday morning Swiss Roche AG confirmed that it is working closely with the World Health Organization (WHO) and governments around the world to make the oral antiviral medication Tamiflu available to patients in need following the increased reports of outbreaks of swine flu. Revenues with the flu therapy , which is active against this new swine flu virus A(H1N1), dropped significantly last year as there were few cases of avian flu.

SpainSpain

08.03.2012

Granada-based Integromics S.L. has teamed up with the Galician Foundation of Genomic Medicine (FPGMX) in Santiago de Compostela to secure a €1m EU grant from the European Regional Development Fund and the Spanish government. With...

SpainSpain

08.03.2012

Oryzon Genomics S.A (Barcelona) is entering preclinical testing with a first-in-class bispecific LSD1/MAO-B inhibitor. In addition to the classic target MAO-B, the drug also blocks histone demethylase LSD1, an epigenetic histone...

SpainSpain

06.03.2012

Granada-based nLife Therapeutics S.L. has raised €5m in total from two venture capitalists. Through Caixa Capital Risc and Caixa Capital Biomed, La Caixa invested €2.5m. The same amount has been placed by Invercaria via its...

SpainSpain

05.03.2012

Ordesa Laboratories has filed a patent for a novel Bifidobacterium strain isolated from infant feces. It has the capacity to combat rotavirus, says a study (Appl. Environ. Microbiol., doi:10.1128/AEM.05548).

SpainSpain

19.12.2011

Madrid – Researchers from Spain and the US have discovered an Ebola-like filovirus in bats in northern Spain. The first known filovirus native to Europe was reported in a study published in the journal PLOS Pathogens...

SpainSpain

15.12.2011

Barcelona - South western Europe gets a new R&D unit in the field of biomolecules. Kymos Pharma, a contract researcher based in Barcelona, has signed an agreement with the French biotechnology group Ipsen to create a R&D group...

SpainSpain

12.12.2011

Barcelona/Saffron Walden – Almirall S.A. and BioFocus announced that they have entered into a collaboration agreement to identify new compounds against key targets in projects aimed at the treatment of respiratory and...

SpainSpain

03.12.2011

Madrid/Abu Dhabi – Spanish biotechs are seeking collaborations with firms in the United Arab Emirates. At the end of November, Grupo Zeltia and 14 other Spanish companies presented their research at the forum “Innovation,...

SpainSpain

01.10.2011

Madrid – The Spanish Minister of Innovation and Science Cristina Garmendia has responded to reports about Roche’s­ delivery stop in Greece and pessimistic expectations for Spain. In Sept­ember, she stressed that the atmosphere...

Displaying results 1 to 10 out of 181

1-10 Next >

© 2007-2014 BIOCOM

http://www.european-biotechnology-news.com/nc/news/messages-archive/archive-spain/article/swine-flu-has-reached-europe.html

Events

All Events

Stock list

All quotes

TOP

  • ADDEX3.51 CHF12.14%
  • STRATEC BIOMEDICAL41.09 EUR4.55%
  • MEDIGENE4.00 EUR2.30%

FLOP

  • CYTOS0.18 CHF-5.26%
  • MOLOGEN6.60 EUR-2.22%
  • SANTHERA86.95 CHF-1.92%

TOP

  • PAION3.22 EUR35.3%
  • CO.DON3.14 EUR28.2%
  • FORMYCON8.20 EUR16.6%

FLOP

  • CYTOS0.18 CHF-30.8%
  • EVOTEC3.10 EUR-15.8%
  • 4SC1.04 EUR-15.4%

TOP

  • SANTHERA86.95 CHF2112.5%
  • PAION3.22 EUR228.6%
  • CO.DON3.14 EUR223.7%

FLOP

  • CYTOS0.18 CHF-95.4%
  • 4SC1.04 EUR-45.0%
  • MOLOGEN6.60 EUR-44.0%

No liability assumed, Date: 30.09.2014


Current issue

All issues

Product of the week

Products